Correlation Between CleanTech Lithium and Ondine Biomedical

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both CleanTech Lithium and Ondine Biomedical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining CleanTech Lithium and Ondine Biomedical into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between CleanTech Lithium plc and Ondine Biomedical, you can compare the effects of market volatilities on CleanTech Lithium and Ondine Biomedical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in CleanTech Lithium with a short position of Ondine Biomedical. Check out your portfolio center. Please also check ongoing floating volatility patterns of CleanTech Lithium and Ondine Biomedical.

Diversification Opportunities for CleanTech Lithium and Ondine Biomedical

-0.78
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between CleanTech and Ondine is -0.78. Overlapping area represents the amount of risk that can be diversified away by holding CleanTech Lithium plc and Ondine Biomedical in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Ondine Biomedical and CleanTech Lithium is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on CleanTech Lithium plc are associated (or correlated) with Ondine Biomedical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Ondine Biomedical has no effect on the direction of CleanTech Lithium i.e., CleanTech Lithium and Ondine Biomedical go up and down completely randomly.

Pair Corralation between CleanTech Lithium and Ondine Biomedical

Assuming the 90 days trading horizon CleanTech Lithium plc is expected to generate 1.6 times more return on investment than Ondine Biomedical. However, CleanTech Lithium is 1.6 times more volatile than Ondine Biomedical. It trades about -0.04 of its potential returns per unit of risk. Ondine Biomedical is currently generating about -0.14 per unit of risk. If you would invest  1,900  in CleanTech Lithium plc on September 12, 2024 and sell it today you would lose (75.00) from holding CleanTech Lithium plc or give up 3.95% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

CleanTech Lithium plc  vs.  Ondine Biomedical

 Performance 
       Timeline  
CleanTech Lithium plc 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days CleanTech Lithium plc has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's technical and fundamental indicators remain rather sound which may send shares a bit higher in January 2025. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.
Ondine Biomedical 

Risk-Adjusted Performance

5 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Ondine Biomedical are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. In spite of rather unsteady technical and fundamental indicators, Ondine Biomedical exhibited solid returns over the last few months and may actually be approaching a breakup point.

CleanTech Lithium and Ondine Biomedical Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with CleanTech Lithium and Ondine Biomedical

The main advantage of trading using opposite CleanTech Lithium and Ondine Biomedical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if CleanTech Lithium position performs unexpectedly, Ondine Biomedical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Ondine Biomedical will offset losses from the drop in Ondine Biomedical's long position.
The idea behind CleanTech Lithium plc and Ondine Biomedical pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.

Other Complementary Tools

Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA